Loading chart...
MRKMRK
$145.04Down 1.49 percent, −$2.20
As of today at 1:04 PM ET
Key Stats
Market Cap$363.266B
Volume (24h)4,252,045
Day's Range$143.48-$147.36
52-Week Range$82.01-$156.92
PE Ratio--
EPS-0.54
Net Income (FY)$18.26B
Revenue (FY)$65.01B
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).
- Website
- merck.com
- Industry
- PHARMACEUTICAL PREPARATIONS
- Full-time Employees
- 75,000
- Headquarters
- RAHWAY
- IPO Date
- Apr 20, 1949
| 24 hours | 5 days | 1 month | YTD | 1 year | All time |
|---|---|---|---|---|---|
Down 1.49 percent | Down 0.62 percent | Down 3.89 percent | Up 36.75 percent | Up 65.55 percent | — |
